Basic info
Industry
pharmaceutical manufacturing
Sectors
kinase inhibitors
research
clinical trials
oncology research
Oncology
pharmaceutics
bio-pharmaceutics
pharma
clinical studies
bio-pharma
hematology
ALK positive lung cancer
cancer research
cancer
ALK inhibitor
investigational agents
clinical research
Health Care
ALK+ NSCLC
Clinical Trials
Therapeutics
Medical
lung cancer
ensartinib
cancer therapy
Date founded
2006
Funding rounds raised
Total raised
$20M
from 1 investors over 1 rounds
X
Xcovery raised $20M on October 29, 2014
Investors: Betta Pharmaceuticals Co., Ltd.